SCOPE 2 – Still Answering the Unanswered Questions in Oesophageal Radiotherapy? SCOPE 2: a Randomised Phase II/III Trial to Study Radiotherapy Dose Escalation in Patients with Oesophageal Cancer Treated with Definitive Chemoradiation with an Embedded Phase II Trial for Patients with a Poor Early Response using Positron Emission Tomography/Computed Tomography

Autor: Bridges, S. ∗, 1, Thomas, B. †, 1, Radhakrishna, G. ‡, Hawkins, M. §, Holborow, A., Hurt, C. ∗, Mukherjee, S. ||, Nixon, L. ∗, 2, Crosby, T. †, 2, Gwynne, S. ¶, ∗∗, 2
Zdroj: In Clinical Oncology July 2022 34(7):e269-e280
Databáze: ScienceDirect
Externí odkaz: